141 related articles for article (PubMed ID: 37972732)
1. HLA Class I Allele Loss and Bone Marrow Transplantation Outcomes in Immune Aplastic Anemia.
Zaimoku Y; Katagiri T; Nakagawa N; Imi T; Maruyama H; Takamatsu H; Ishiyama K; Yamazaki H; Miyamoto T; Nakao S
Transplant Cell Ther; 2024 Mar; 30(3):281.e1-281.e13. PubMed ID: 37972732
[TBL] [Abstract][Full Text] [Related]
2. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors.
Morishima Y; Sasazuki T; Inoko H; Juji T; Akaza T; Yamamoto K; Ishikawa Y; Kato S; Sao H; Sakamaki H; Kawa K; Hamajima N; Asano S; Kodera Y
Blood; 2002 Jun; 99(11):4200-6. PubMed ID: 12010826
[TBL] [Abstract][Full Text] [Related]
3. HLA associations, somatic loss of HLA expression, and clinical outcomes in immune aplastic anemia.
Zaimoku Y; Patel BA; Adams SD; Shalhoub R; Groarke EM; Lee AAC; Kajigaya S; Feng X; Rios OJ; Eager H; Alemu L; Quinones Raffo D; Wu CO; Flegel WA; Young NS
Blood; 2021 Dec; 138(26):2799-2809. PubMed ID: 34724566
[TBL] [Abstract][Full Text] [Related]
4. High-risk HLA alleles for severe acute graft-versus-host disease and mortality in unrelated donor bone marrow transplantation.
Morishima S; Kashiwase K; Matsuo K; Azuma F; Yabe T; Sato-Otsubo A; Ogawa S; Shiina T; Satake M; Saji H; Kato S; Kodera Y; Sasazuki T; Morishima Y;
Haematologica; 2016 Apr; 101(4):491-8. PubMed ID: 26768690
[TBL] [Abstract][Full Text] [Related]
5. A study assessing the feasibility of randomization of pediatric and young adult patients between matched unrelated donor bone marrow transplantation and immune-suppressive therapy for newly diagnosed severe aplastic anemia: A joint pilot trial of the North American Pediatric Aplastic Anemia Consortium and the Pediatric Transplantation and Cellular Therapy Consortium.
Pulsipher MA; Lehmann LE; Bertuch AA; Sasa G; Olson T; Nakano T; Gilio A; Burroughs LM; Lipton JM; Huang JN; Dickerson K; Bertaina A; Zhuang C; Malsch M; Fleming M; Weller E; Shimamura A; Williams DA
Pediatr Blood Cancer; 2020 Oct; 67(10):e28444. PubMed ID: 32776425
[TBL] [Abstract][Full Text] [Related]
6. First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia.
Peinemann F; Bartel C; Grouven U
Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD006407. PubMed ID: 23881658
[TBL] [Abstract][Full Text] [Related]
7. Association between human leukocyte antigen and immunosuppressive treatment outcomes in Chinese patients with aplastic anemia.
Chen L; Ge M; Huo J; Ren X; Shao Y; Li X; Huang J; Wang M; Nie N; Zhang J; Peng J; Zheng Y
Front Immunol; 2023; 14():1056381. PubMed ID: 36793734
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic stem cell transplantation for acquired aplastic anemia.
Georges GE; Storb R
Curr Opin Hematol; 2016 Nov; 23(6):495-500. PubMed ID: 27607445
[TBL] [Abstract][Full Text] [Related]
9. Effect of HLA class I or class II incompatibility in pediatric marrow transplantation from unrelated and related donors.
Leung WH; Turner V; Richardson SL; Benaim E; Hale G; Horwitz EM; Woodard P; Bowman LC
Hum Immunol; 2001 Apr; 62(4):399-407. PubMed ID: 11295473
[TBL] [Abstract][Full Text] [Related]
10. Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment.
Georges GE; Doney K; Storb R
Blood Adv; 2018 Aug; 2(15):2020-2028. PubMed ID: 30108110
[TBL] [Abstract][Full Text] [Related]
11. Frequent loss of HLA alleles associated with copy number-neutral 6pLOH in acquired aplastic anemia.
Katagiri T; Sato-Otsubo A; Kashiwase K; Morishima S; Sato Y; Mori Y; Kato M; Sanada M; Morishima Y; Hosokawa K; Sasaki Y; Ohtake S; Ogawa S; Nakao S;
Blood; 2011 Dec; 118(25):6601-9. PubMed ID: 21963603
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome of acquired aplastic anaemia in children: comparison between immunosuppressive therapy and bone marrow transplantation.
Kojima S; Horibe K; Inaba J; Yoshimi A; Takahashi Y; Kudo K; Kato K; Matsuyama T
Br J Haematol; 2000 Oct; 111(1):321-8. PubMed ID: 11091219
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic unrelated bone marrow transplantation from older donors results in worse prognosis in recipients with aplastic anemia.
Arai Y; Kondo T; Yamazaki H; Takenaka K; Sugita J; Kobayashi T; Ozawa Y; Uchida N; Iwato K; Kobayashi N; Takahashi Y; Ishiyama K; Fukuda T; Ichinohe T; Atsuta Y; Mori T; Teshima T;
Haematologica; 2016 May; 101(5):644-52. PubMed ID: 26858357
[TBL] [Abstract][Full Text] [Related]
14. A frequent nonsense mutation in exon 1 across certain HLA-A and -B alleles in leukocytes of patients with acquired aplastic anemia.
Mizumaki H; Hosomichi K; Hosokawa K; Yoroidaka T; Imi T; Zaimoku Y; Katagiri T; Anh Thi Nguyen M; Cao Tran D; Ibrahim Yousef Elbadry M; Chonabayashi K; Yoshida Y; Takamatsu H; Ozawa T; Azuma F; Kishi H; Fujii Y; Ogawa S; Tajima A; Nakao S
Haematologica; 2021 Jun; 106(6):1581-1590. PubMed ID: 32439725
[TBL] [Abstract][Full Text] [Related]
15. Decision analysis of allogeneic bone marrow transplantation versus immunosuppressive therapy for young adult patients with aplastic anemia.
Kanda Y; Usuki K; Inagaki M; Ohta A; Ogasawara Y; Obara N; Kako S; Kurokawa M; Shimada N; Suzuki T; Hama A; Yamaguchi H; Nakao S; Yamazaki H
Int J Hematol; 2023 May; 117(5):660-668. PubMed ID: 36595144
[TBL] [Abstract][Full Text] [Related]
16. First-line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapy.
Yoshida N; Kobayashi R; Yabe H; Kosaka Y; Yagasaki H; Watanabe K; Kudo K; Morimoto A; Ohga S; Muramatsu H; Takahashi Y; Kato K; Suzuki R; Ohara A; Kojima S
Haematologica; 2014 Dec; 99(12):1784-91. PubMed ID: 25193958
[TBL] [Abstract][Full Text] [Related]
17. Pathogenicity and impact of HLA class I alleles in aplastic anemia patients of different ethnicities.
Olson TS; Frost BF; Duke JL; Dribus M; Xie HM; Prudowsky ZD; Furutani E; Gudera J; Shah YB; Ferriola D; Dinou A; Pagkrati I; Kim S; Xu Y; He M; Zheng S; Nijim S; Lin P; Xu C; Nakano TA; Oved JH; Carreno BM; Bolon YT; Gadalla SM; Marsh SG; Paczesny S; Lee SJ; Monos DS; Shimamura A; Bertuch AA; Gragert L; Spellman SR; Babushok DV
JCI Insight; 2022 Nov; 7(22):. PubMed ID: 36219480
[TBL] [Abstract][Full Text] [Related]
18. Choice of conditioning regimens for bone marrow transplantation in severe aplastic anemia.
Bejanyan N; Kim S; Hebert KM; Kekre N; Abdel-Azim H; Ahmed I; Aljurf M; Badawy SM; Beitinjaneh A; Boelens JJ; Diaz MA; Dvorak CC; Gadalla S; Gajewski J; Gale RP; Ganguly S; Gennery AR; George B; Gergis U; Gómez-Almaguer D; Vicent MG; Hashem H; Kamble RT; Kasow KA; Lazarus HM; Mathews V; Orchard PJ; Pulsipher M; Ringden O; Schultz K; Teira P; Woolfrey AE; Saldaña BD; Savani B; Winiarski J; Yared J; Weisdorf DJ; Antin JH; Eapen M
Blood Adv; 2019 Oct; 3(20):3123-3131. PubMed ID: 31648332
[TBL] [Abstract][Full Text] [Related]
19. High Failure-Free Survival after Unrelated Donor Peripheral Blood Stem Cell Transplantation in Pediatric Severe Aplastic Anemia.
Yoo JW; Kim S; Lee JW; Jang PS; Jeong DC; Cho B; Chung NG
Transplant Cell Ther; 2022 Feb; 28(2):103.e1-103.e8. PubMed ID: 34823062
[TBL] [Abstract][Full Text] [Related]
20. Feasibility and results of bone marrow transplantation from an HLA-mismatched unrelated donor for children and young adults with acquired severe aplastic anemia.
Yagasaki H; Takahashi Y; Kudo K; Ohashi H; Hama A; Yamamoto T; Tanaka M; Yoshida N; Hidaka H; Nishio N; Kojima S
Int J Hematol; 2007 Jun; 85(5):437-42. PubMed ID: 17562622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]